This story has been updated from a previous version.  

NEW YORK, Oct. 2 – Bayer said Tuesday that it had agreed to acquire Aventis CropScience from Aventis and Schering for 7.25 billion euros ($6.63 billion), including debt, a deal that will propel Bayer to the number two spot in the agrochemicals sector.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.